Dillon & Associates’s Imunon IMNN Stock Holding History

Dillon & Associates’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-114	Closed	-$12K	–	80
2021 Q4	$12K	Hold	114	–	–	﹤0.01%	77
2021 Q3	$21K	Hold	114	–	–	﹤0.01%	71
2021 Q2	$22K	Hold	114	–	–	﹤0.01%	70
2021 Q1	$22K	Hold	114	–	–	﹤0.01%	71
2020 Q4	$16K	Hold	114	–	–	﹤0.01%	65
2020 Q3	$16K	Hold	114	–	–	﹤0.01%	66
2020 Q2	$89K	Hold	114	–	–	0.02%	67
2020 Q1	$20K	Hold	114	–	–	0.01%	64
2019 Q4	$45K	Hold	114	–	–	0.01%	66
2019 Q3	$45K	Hold	114	–	–	0.01%	65
2019 Q2	$45K	Hold	114	–	–	0.01%	65
2019 Q1	$45K	Buy	114 +2	+2%	+$829	0.01%	65
2018 Q4	$22K	Buy	112 +51	+84%	+$21.2K	0.01%	64
2018 Q3	$36K	Hold	61	–	–	0.01%	71
2018 Q2	$36K	Hold	61	–	–	0.01%	68
2018 Q1	$24K	Buy	+61	New	+$29.3K	0.01%	67
2013 Q3	–	Sell	-1	Closed	-$12K	–	63
2013 Q2	$12K	Buy	+1	New	+$13.9K	0.01%	60

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Dillon & Associates's IMNN Position: Q1 2022 in Review

Dillon & Associates sold out of Imunon (IMNN) in Q1 2022, closing a stake of 114 shares — an estimated $12K sold.

Dillon & Associates first reported a position in IMNN in Q2 2013 and held it in 17 quarters. The position peaked at $89K in Q2 2020. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

Dillon & Associates reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
Dillon & Associates sold 114 Imunon shares in Q1 2022, an estimated $12K.
Dillon & Associates first reported a position in Imunon in Q2 2013 and held it in 17 quarters.
Dillon & Associates's Imunon position peaked at $89K in Q2 2020.
23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on Dillon & Associates's 13F filing for Q1 2022, filed 6 May 2022.